BRPI0819105A2 - composição para o tratamento e prevenção de edema de pálpebra - Google Patents

composição para o tratamento e prevenção de edema de pálpebra

Info

Publication number: BRPI0819105A2
Authority: BR; Brazil
Prior art keywords: prevention; treatment; composition; eyelid edema; eyelid
Prior art date: 2007-11-08

Application number

BRPI0819105A

Other languages

English (en)

Inventor

Minno George

Jeffrey Lane Keith

Barry Abelson Mark

Jonathan Chapin Matthew

Original Assignee

Aciex Therapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-11-08

Filing date

2008-11-06

Publication date

2019-09-24

2008-11-06 Application filed by Aciex Therapeutics Inc filed Critical Aciex Therapeutics Inc

2019-09-24 Publication of BRPI0819105A2 publication Critical patent/BRPI0819105A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BRPI0819105A 2007-11-08 2008-11-06 composição para o tratamento e prevenção de edema de pálpebra BRPI0819105A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US751107P	2007-11-08	2007-11-08
PCT/US2008/012513 WO2009061431A2 (en)	2007-11-08	2008-11-06	Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor

Publications (1)

Publication Number	Publication Date
BRPI0819105A2 true BRPI0819105A2 (pt)	2019-09-24

Family

ID=40329067

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0819105A BRPI0819105A2 (pt)	2007-11-08	2008-11-06	composição para o tratamento e prevenção de edema de pálpebra

Country Status (8)

Country	Link
EP (1)	EP2219630A2 (pt)
JP (1)	JP2011503061A (pt)
CN (1)	CN101977595A (pt)
AU (1)	AU2008325214A1 (pt)
BR (1)	BRPI0819105A2 (pt)
CA (1)	CA2705050A1 (pt)
MX (1)	MX2010005012A (pt)
WO (1)	WO2009061431A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20120225918A1 (en) *	2011-03-03	2012-09-06	Voom, Llc	Compositions and Methods for Non-Surgical Treatment of Ptosis
IN2014CN03950A (pt) *	2011-11-01	2015-10-16	Rohto Pharma
EA021247B1 (ru) *	2012-03-26	2015-05-29	Ооо "Фармацевтическая Компания "Славянская Аптека"	Фармацевтический состав, обладающий сосудосуживающим, антиконгестивным, противовоспалительным действием (варианты)
EA021234B1 (ru) *	2012-03-27	2015-05-29	Ооо "Фармацевтическая Компания "Славянская Аптека"	Фармацевтический состав, обладающий сосудосуживающим, антиконгестивным, противовоспалительным действием (варианты)
JP6373551B2 (ja) *	2012-05-30	2018-08-15	味の素株式会社	ガロタンニン含有組成物
AU2013201465B2 (en)	2012-10-24	2016-03-03	Rayner Intraocular Lenses Limited	Stable preservative-free mydriatic and anti-inflammatory solutions for injection
US20140329874A1 (en) *	2013-05-06	2014-11-06	Allergan, Inc.	Alpha adrenergic agonists for the treatment of tissue trauma
TWI705812B (zh)	2014-12-01	2020-10-01	奥默羅斯公司	用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
US9820954B2 (en)	2015-08-19	2017-11-21	Jenivision Inc.	Quantitative peri-orbital application of ophthalmology drugs
CN115006537A (zh)	2016-01-26	2022-09-06	利维申制药有限公司	α-肾上腺素能药剂的组合物和用途
EP3970803A1 (en) *	2020-09-22	2022-03-23	Beiersdorf AG	Cosmetic composition of low osmolality
WO2022187306A1 (en) *	2021-03-03	2022-09-09	Voom, Llc	Compositions and methods for treatment of blepharitis
AU2023352919A1 (en)	2022-09-29	2025-03-13	Adora Animal Health Corporation	Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions
CN117771183B (zh) *	2024-02-27	2024-05-03	深圳大佛药业股份有限公司	一种盐酸羟甲唑啉喷雾剂及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2618428A (en) *	1947-01-27	1952-11-18	John K M Harrison	Shock resistant container
US5188826A (en) *	1988-02-08	1993-02-23	Insite Vision Incorporated	Topical ophthalmic suspensions
IT1248014B (it) *	1991-06-07	1995-01-05	Inverni Della Beffa Spa	Preparazioni oftalmiche a rilascio protratto
US5811446A (en) *	1997-04-18	1998-09-22	Cytos Pharmaceuticals Llc	Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
US7691829B2 (en) *	1998-03-24	2010-04-06	Petito George D	Composition and method for healing tissues
US6274626B1 (en) *	1998-12-22	2001-08-14	Bausch & Lomb Incorporated	Pheniramine-containing compositions and method for treating allergic responses
JP2001187728A (ja) *	1999-12-28	2001-07-10	Lion Corp	眼科用組成物
DE10000612A1 (de) *	2000-01-10	2001-07-19	Min Becker	Flüssigkeitspräparate für Augen- und Nasen-Tropfen bzw. Nasenspray ohne Konservierungsmittel
JP2002308775A (ja) *	2001-04-06	2002-10-23	Rohto Pharmaceut Co Ltd	外用組成物
US7288263B2 (en) *	2004-09-13	2007-10-30	Evera Laboratories, Llc	Compositions and methods for treatment of skin discoloration
LT2522365T (lt) *	2004-11-24	2017-02-10	Meda Pharmaceuticals Inc.	Kompozicijos, apimančios azelastiną, ir jų panaudojimo būdai
JP2006232792A (ja) *	2005-02-21	2006-09-07	Aile De Beaute:Kk	肌老化改善化粧料
NZ571690A (en) *	2006-03-31	2011-09-30	Vistakon Pharmaceuticals Llc	Ocular allergy treatments using alcaftadine
EP2015733A2 (en) *	2006-04-26	2009-01-21	Aciex, Inc.	Compositions for the treatment and prevention of eyelid swelling

2008
- 2008-11-06 AU AU2008325214A patent/AU2008325214A1/en not_active Abandoned
- 2008-11-06 JP JP2010533093A patent/JP2011503061A/ja not_active Withdrawn
- 2008-11-06 BR BRPI0819105A patent/BRPI0819105A2/pt not_active IP Right Cessation
- 2008-11-06 CA CA2705050A patent/CA2705050A1/en not_active Abandoned
- 2008-11-06 CN CN2008801191850A patent/CN101977595A/zh active Pending
- 2008-11-06 WO PCT/US2008/012513 patent/WO2009061431A2/en not_active Ceased
- 2008-11-06 EP EP08847794A patent/EP2219630A2/en not_active Withdrawn
- 2008-11-06 MX MX2010005012A patent/MX2010005012A/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN101977595A (zh)	2011-02-16
EP2219630A2 (en)	2010-08-25
JP2011503061A (ja)	2011-01-27
CA2705050A1 (en)	2009-05-14
AU2008325214A1 (en)	2009-05-14
WO2009061431A2 (en)	2009-05-14
MX2010005012A (es)	2010-06-23
WO2009061431A3 (en)	2009-07-23

Similar Documents

Publication	Publication Date	Title
BRPI0819105A2 (pt)	2019-09-24	composição para o tratamento e prevenção de edema de pálpebra
CY2023002I1 (el)	2023-06-09	Συνθεσεις και χρησεις για αντιμετωπιση πολλαπλης σκληρυνσης
PT1881823E (pt)	2015-03-02	Composições e métodos para o tratamento de transtornos oculares
BRPI0819241A2 (pt)	2015-05-05	Compostos derivados de amina para o tratamento de distúrbios e doenças oftálmicas
CR11019A (es)	2009-10-20	3-imidazolil-indoles para el tratamiento de enfermedades proliferativas
BRPI0919920A2 (pt)	2016-02-16	compostos para tratamento de doenças e desordens oftálmicas
BRPI0916862A2 (pt)	2016-02-10	compostos úteis para o tratamento de doenças degenerativas e inflamatórias
PT2894165T (pt)	2023-03-17	Métodos e composições para o tratamento de distúrbios associados ao complemento
ES2525801T8 (es)	2018-03-20	Composiciones y métodos para la prevención y el tratamiento de enfermedades autoinmunes
BRPI0716844A2 (pt)	2013-10-22	Inidores de quinase úteis para o tratamento de doenças proliferativas
BRPI0818799A2 (pt)	2015-04-22	Composições para o tratamento da doença de parkinson
PL3354276T3 (pl)	2020-09-21	Kompozycje do leczenia zapalenia przewodu pokarmowego
BRPI0921321A2 (pt)	2018-10-16	métodos para o tratamento de indwcções e tumores
BRPI0915282A2 (pt)	2017-02-07	agonistas mistos baseados no gip para o tratamento de distúrbios metabólicos e obesidade
PT2367561E (pt)	2015-10-23	Composições e métodos para o tratamento da doença celíaca
BRPI0917444A2 (pt)	2015-12-01	composições farmacêuticas de retenção gástrica para o tratamento e prevenção de doenas do snc
BRPI0813725A2 (pt)	2014-12-30	Métodos e composições para tratamento de doenças
BRPI1015569A2 (pt)	2016-08-16	compostos úteis para o tratamento de doenças degenerativas e inflamatórias.
BRPI0816712A2 (pt)	2016-11-08	terapia de intervalo para o tratamento de tinnitus
BRPI1007929A2 (pt)	2015-09-01	"métodos e composições para o tratamento de neovascularização".
BRPI0911612A2 (pt)	2015-12-15	composições e métodos para o tratamento da esclerose múltipla.
PL2205720T3 (pl)	2017-06-30	Kompozycja do leczenia stwardnienia rozsianego
BRPI0917440A2 (pt)	2015-12-01	composições farmacêuticas oftálmicas para o tratamento de patologias neoangiogênicas do olho
BRPI0923567A2 (pt)	2016-09-27	agentes antibactericidas novos para o tratamento de infecções gram positivas
BRPI0914454A2 (pt)	2015-10-27	"composição para o tratamento do tecido epitelial"

Legal Events

Date	Code	Title	Description
2019-10-01	B08F	Application fees: dismissal - article 86 of industrial property law
2020-01-21	B08K	Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.